再鼎医药(09688.HK)获摩根大通增持192.01万股

Group 1 - JPMorgan Chase & Co. increased its stake in Zai Lab Limited (09688.HK) by purchasing 1.9201 million shares at an average price of HKD 13.3426 per share, totaling approximately HKD 25.619 million [1] - Following this acquisition, JPMorgan's total holdings in Zai Lab rose to 56.4703 million shares, increasing its ownership percentage from 4.87% to 5.04% [1]